Results per Page:
AMP-ed on HIV prevention
From the McElrath Lab, Vaccine and Infectious Disease Division
First in-human HIV vaccine to induce virus-specific neutralizing antibodies
From the McElrath Lab, Vaccine and Infectious Disease and Clinical Research Divisions
A promising HIV vaccine candidate gets a little help
New strategy stirs a robust response from T cells tracked by McElrath lab
Researchers identify strong T-cell response in first-in-human nanoparticle HIV vaccine
Study result moves scientists closer to developing elusive HIV vaccine
Test of a new 'germline-targeting' HIV vaccine prepares to launch
Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus
New strategy to weather the (cytokine) storm
From the Gujral Lab, Human Biology Division
Q&A: Dr. Larry Corey at the center of COVID-19 vaccine research
Fred Hutch scientists will play key roles in 'harmonizing' clinical trials
How Fred Hutch is using science to get back to doing science
Physical distancing, masks, testing and lots of research drive 'back-to-campus' strategy
‘Don’t stop now’: an endgame for HIV/AIDS
HBO’s ‘Countdown to Zero,’ featuring Fred Hutch researchers, shows the pandemic remains, but fresh hope abounds
Madame Peng Liyuan, first lady of China, visits Fred Hutch
Bill and Melinda Gates, Nobel-winner Dr. Linda Buck among luminaries meeting and touring Hutch HIV vaccine lab